KR20220013765A - Interdigitated electrode type microneedle patches - Google Patents

Abstract

The present invention provides a microneedle patch in which a microneedle is inserted into the skin tissue and directly provides electrical stimulation to effectively implement skin regeneration. According to an embodiment of the present invention, the microneedle patch comprises: an electrode unit that provides an electrical signal in contact with the patient's skin, and includes a first electrode unit and a second electrode unit spaced apart from the first electrode unit; and a plurality of microneedles connected to the electrode unit, and a plurality of microneedles are formed at regular intervals along the electrode unit, and pass through the stratum corneum of the skin to deliver an active ingredient directly to the tissue inside the skin.

Description

Interdigitated electrode type microneedle patches

The technical idea of the present invention relates to a skin treatment device, and more particularly, to a cross-electrode microneedle patch for treatment using a needle patch capable of injecting a drug or cosmetic ingredient into a patient.

The microneedle is a system that physically punches a small hole in the stratum corneum of the skin and uses the passage to deliver the drug, and can deliver the drug at a speed about 100 times higher than that of the existing transdermal delivery system. The recently used or developed microneedle-based delivery method is a solid form in which a drug is applied after forming a hole in the skin, and a form in which the drug is delivered by needle administration itself, that is, the drug is a molten form embedded in the needle or applied to the surface of the needle. It can be divided into coating type.

In general, microneedles are used for delivery of active substances such as drugs and vaccines in vivo, detection of analytes in the body, and biopsy. Delivery of pharmaceutical or chemically active ingredients using microneedles aims to deliver active substances through the skin, not the biological circulation system such as blood vessels or lymphatic vessels. Therefore, the microneedle should have sufficient physical strength to allow penetration of the skin, and it is preferable that the microneedle has less pain. In order to reduce pain as much as possible, it is advantageous that the skin application time of the microneedle is shorter, and in this case, the active substance should be able to be delivered quickly.

Patent Publication No. 10-2020-0001213

However, such a conventional microneedle may cause pain to the patient as it takes a long time for the drug or cosmetic ingredient contained or coated in the needle to penetrate into the tissue in the skin, and also maximize the therapeutic effect of the injected drug or cosmetic ingredient. In order to do this, there was a problem in that when light therapy was concurrently applied, the light could not penetrate deeply into the skin through the microneedle, resulting in poor therapeutic effect.

The present invention is to solve various problems including the above problems, and induces the drug or cosmetic ingredient to penetrate into the tissue within the skin within a short time effectively, and forms an optical path on the surface of the needle with electrical stimulation. To provide a cross-electrode microneedle patch that can effectively penetrate into the skin tissue together with drugs or cosmetic ingredients to maximize the therapeutic effect of the patient through the interaction between drug and phototherapy when phototherapy is combined. do.

However, these tasks are exemplary, and the technical spirit of the present invention is not limited thereto.

According to one aspect of the present invention, there is provided a microneedle patch in which the microneedle is inserted into the skin tissue and directly provides electrical stimulation to effectively implement skin regeneration.

According to an embodiment of the present invention, the microneedle patch provides an electrical signal in contact with the patient's skin, and includes a first electrode part and a second electrode part spaced apart from the first electrode part. wealth; and a plurality of microneedles connected to the electrode part, formed at regular intervals along the electrode part, and passing through the stratum corneum of the skin to deliver the active ingredient directly to the tissue inside the skin.

According to an embodiment of the present invention, the first electrode part and the second electrode part may be alternately disposed with each other.

According to an embodiment of the present invention, the first electrode part may include a first coalescing unit and a plurality of first extension units differentiated from and extending from the first coalescing unit. The second electrode unit may include a second coalescing unit and a plurality of second extension units differentiated from and extending from the second united unit. The first extension parts and the second extension parts may be alternately disposed to be spaced apart from each other.

According to an embodiment of the present invention, the first electrode part may extend to be wound inwardly in a first rotational direction, and the second electrode part may be wound inwardly in a second rotational direction opposite to the first rotational direction. It may extend so as to be spaced apart between the first electrode parts.

According to an embodiment of the present invention, the first electrode part and the second electrode part may each extend in a curved shape.

According to an embodiment of the present invention, the first electrode part and the second electrode part may each extend in a straight line.

According to an embodiment of the present invention, the electrode part has a through hole, the microneedle may be disposed to protrude in the through hole, and the through hole accommodates the active ingredient, and the microneedle receives the active ingredient. By supplying the active ingredient, the active ingredient can be penetrated into the skin through the microneedle.

According to an embodiment of the present invention, an adhesive sheet may be formed on one surface of the electrode unit to be adhered to the skin.

According to an embodiment of the present invention, a power supply unit electrically connected to the electrode unit to provide power; may further include.

According to an embodiment of the present invention, the power supply unit may provide DC power, AC power, RF power, or pulse power to the electrode unit.

According to an embodiment of the present invention, the power supply unit may be composed of a galvanic battery or a triboelectric generator.

According to an embodiment of the present invention, the power supply unit may include a battery composed of an iron electrode, a hydrogel, and a magnesium electrode.

According to an embodiment of the present invention, the microneedle is formed to have a narrower width from the connecting portion with the electrode to the tip so that the microneedle can easily pass through the stratum corneum of the skin, so that the tip is pointed. can be formed.

According to an embodiment of the present invention, the microneedle is concave along the longitudinal direction of the microneedle so that, during phototherapy, the treatment light irradiated from the light source along the microneedle can easily penetrate to the inside of the skin. It may further include a; formed in the optical groove.

According to an embodiment of the present invention, the microneedle penetrates a part of the patch body and a part of the microneedle in a slot shape so that the treatment light can easily reach the optical groove formed in the microneedle. It may further include a; through slot portion formed to be connected to one side of the optical groove portion.

According to one embodiment of the present invention, the optical groove portion, the length in the width direction may be formed to be smaller than the length in the depth direction so that the tissue of the skin does not block the optical path of the treatment light by filling the optical groove portion.

According to an embodiment of the present invention, the optical groove portion may further include a protrusion formed to protrude from both sides of the optical groove portion by solidifying the molten metal material around the optical groove portion during laser processing.

According to an embodiment of the present invention, the electrode part includes copper (Cu), aluminum (Al), iron (Fe), magnesium (Mg), titanium (Ti), gold (Au), silver (Ag), rubidium ( Ru), platinum (Pt), iridium (Ir), molybdenum (Mo), palladium (Pd), zinc (Zn), silicon (Si), nickel (Ni), tin (Sn), tungsten (W), iron ( Fe), calcium (Ca), potassium (K), sodium (Na), a-IGZO, germanium (Ge), or an alloy thereof may be included.

According to an embodiment of the present invention, the microneedle is magnesium (Mg), iron (Fe), zinc (Zn), molybdenum (Mo), tungsten (W), calcium (Ca), potassium (K), sodium ( Na), silicon (Si), a-IGZO, germanium (Ge), or an alloy thereof may be included.

According to an embodiment of the present invention, it further includes a substrate on which the electrode part is disposed, wherein the substrate is polyimide, polydimethylsiloxane (PDMS), PMMA, ecoflex, dragon-skin, PVP, PVA. , poly(lactic-co-glycolic acid (PLGA), silk fibroin, polycaprolactone (PCL), poly glycolic acid (PGA), poly lactic acid (PLA), poly glycerol sebacate (PGS), PBAT, collagen and rice paper, agarose It may include at least one of gel, and polyanhydrides.

According to the technical idea of the present invention, the microneedle patch penetrates the microneedle into the skin to provide an electrical signal, thereby healing and restoring damaged cells in the skin's internal tissue. In addition, by applying an active ingredient such as a drug or a cosmetic ingredient to the surface of the microneedle, the electric signal enhances the intradermal delivery of the active ingredient and accelerates cell division, thereby effectively performing skin regeneration treatment. have. In addition, it induces the drug to effectively penetrate into the tissue within the skin within a short time, and an optical path is formed on the surface of the needle. It is possible to maximize the therapeutic effect of the patient through the action.

The microneedle patch according to the technical idea of the present invention can be applied as an acne patch. In the case of blocking drug delivery through the self-protective film, such as acne bacteria, the microneedle can penetrate the skin barrier and deliver the drug directly to acne bacteria, so it can be applied as an acne treatment patch.

The microneedle patch according to the technical idea of the present invention can increase the skin delivery efficiency of cosmetic ingredients. In the case of cosmetic ingredients that require moisture absorption into the skin, such as moisture creams and nourishing creams, the effect of skin beauty can be maximized by inducing mechanical stimulation and regeneration of the skin and increasing the efficiency of delivery of cosmetic ingredients to the endothelium.

The above-described effects of the present invention have been described by way of example, and the scope of the present invention is not limited by these effects.

1 is a cross-sectional view showing a microneedle patch according to an embodiment of the present invention.
Figure 2 is a perspective view showing in detail the electrode part and the microneedle of the microneedle patch of Figure 1 according to an embodiment of the present invention.
3 is a real photograph showing in detail the electrode part and the microneedle of the microneedle patch of FIG. 1 according to an embodiment of the present invention.
4 to 6 are schematic views showing the electrode portion of the microneedle patch of Figure 1 according to an embodiment of the present invention.
7 is a perspective view illustrating the microneedle of the microneedle patch of FIG. 1 according to an embodiment of the present invention.
8 to 10 are cross-sectional views illustrating microneedles of the microneedle patch of FIG. 1 according to an embodiment of the present invention.
11 is a cross-sectional view schematically illustrating a phototherapy by attaching an optical patch to the microneedle patch of FIG. 1 according to an embodiment of the present invention.
12 is a schematic diagram illustrating a simulation device for an operation test of a microneedle patch according to an embodiment of the present invention.
13 is a photograph showing a simulating device for an operation test of a microneedle patch according to an embodiment of the present invention.
FIG. 14 shows a result of not applying an electrical signal to the simulating device of the microneedle patch of FIG. 13 according to an embodiment of the present invention.
15 and 16 show a result of applying an electrical signal to the imitation device of the microneedle patch of FIG. 13 according to an embodiment of the present invention.
FIG. 17 is a graph showing the results for the apparatus for simulating the microneedle patch of FIG. 13 according to an embodiment of the present invention.
18 and 19 show the results when triboelectric electricity is applied to the simulating device of the microneedle patch according to an embodiment of the present invention.

Hereinafter, several preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings. Examples of the present invention are provided to more completely explain the present invention to those of ordinary skill in the art, and the following examples may be modified in various other forms, and the scope of the present invention is as follows It is not limited to an Example. Rather, these embodiments are provided so as to more fully and complete the present disclosure, and to fully convey the spirit of the present invention to those skilled in the art. In addition, in the drawings, the thickness or size of each layer is exaggerated for convenience and clarity of description. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, embodiments of the present invention will be described with reference to the drawings schematically illustrating ideal embodiments of the present invention. In the drawings, variations of the illustrated shape can be envisaged, for example depending on manufacturing technology and/or tolerances. Accordingly, embodiments of the spirit of the present invention should not be construed as limited to the specific shape of the region shown in the present specification, but should include, for example, changes in shape caused by manufacturing.

1 is a cross-sectional view showing a microneedle patch 100 according to an embodiment of the present invention.

FIG. 2 is a perspective view showing in detail the electrode part 120 and the microneedle 150 of the microneedle patch 100 of FIG. 1 according to an embodiment of the present invention.

1 and 2 , the microneedle patch 100 includes a substrate 110 , an electrode unit 120 , a microneedle 150 , and a power supply unit 160 .

The electrode unit 120 is disposed on the substrate 110 . The substrate 110 is an optional component and may be omitted. The substrate 110 may include various non-conductive materials. The substrate 110 may include a material capable of providing flexible properties or a flexible substrate having a thickness. The substrate 110 may include, for example, glass, ceramic, fiber, carbon fiber, a polymer material, etc., for example, polyimide, polydimethylsiloxane (PDMS), PMMA, ecoflex, or dragon skin. -skin), PVP, PVA, poly(lactic-co-glycolic acid (PLGA), silk fibroin, polycaprolactone (PCL), poly glycolic acid (PGA), poly lactic acid (PLA), poly glycerol sebacate (PGS), PBAT , may include at least one of collagen and rice paper, agarose gel, and polyanhydrides.

The electrode unit 120 may provide an electrical signal by contacting the patient's skin. The electrode part 120 may include a first electrode part 130 and a second electrode part 140 spaced apart from the first electrode part 130 . The electrode part 120 may include a conductive material, for example, a metal. The electrode part 120 is, for example, copper (Cu), aluminum (Al), iron (Fe), magnesium (Mg), titanium (Ti), gold (Au), silver (Ag), rubidium (Ru), Platinum (Pt), iridium (Ir), molybdenum (Mo), palladium (Pd), zinc (Zn), silicon (Si), nickel (Ni), tin (Sn), tungsten (W) or alloys thereof can do. In addition, the electrode part 120 may include a biodegradable metal material, for example, magnesium (Mg), iron (Fe), zinc (Zn), molybdenum (Mo), tungsten (W), calcium (Ca) , potassium (K), sodium (Na), silicon (Si), a-IGZO, germanium (Ge), or an alloy thereof. The first electrode part 130 and the second electrode part 140 may be formed of the same material or different materials. The shape of the electrode part 120 will be described in detail below.

The microneedles 150 are connected to the electrode part 120 and may be formed in plurality at regular intervals along the electrode part 120 . The microneedles 150 may be formed along one side of the electrode unit 120 , along both sides, or formed along the central portion. The microneedle 150 may pass through the stratum corneum of the skin to deliver an active ingredient such as a drug or a cosmetic ingredient directly to the tissue inside the skin. The microneedle 150 may include a biodegradable metal material. The biodegradability means a substance that can be absorbed in the human body and is harmless after absorption. The microneedle 150 is, for example, magnesium (Mg), iron (Fe), zinc (Zn), molybdenum (Mo), tungsten (W), calcium (Ca), potassium (K), sodium (Na), It may include silicon (Si), a-IGZO, germanium (Ge), or an alloy thereof.

The power supply unit 160 may be electrically connected to the electrode unit 120 to provide power. The power supply unit 160 may be connected to the electrode unit 120 through the wiring 170 . The power supply unit 160 may provide DC power, AC power, RF power, or pulse power to the electrode unit 120 . The power supply unit 160 may be composed of a galvanic battery or a triboelectric generator. The power supply unit 160 may include a battery including an iron electrode, a hydrogel, and a magnesium electrode. The triboelectric generator may be formed using metal deposition on a biodegradable polymer film.

When describing the triboelectric power generator, surface charges are generated according to different heats of charge between the two materials, and opposite (+) and (-) charges of the same amount but different from each other are generated and static electricity is formed. do. The generated opposite charges exist at the contact point between the layers or materials, resulting in a heat of charge. When the external stress is removed, electrons flow to the external circuit, enabling the movement of current. The triboelectric power generator may have, for example, a shape in which a polymer layer, a dielectric layer, and a metal layer are stacked. The polymer layer may include polyethylene terephthalate (PET), polyethylene naphthalate (PEN), and polyimide (PI). The dielectric layer is TiO ₂ , HfO ₂ , ZrO ₂ , Ta ₂ O ₅ , Nb ₂ O ₅ , La ₂ O ₃ , Gd ₂ O ₃ , Er ₂ O ₃ , Sm ₂ O ₃ , (AlTi)O ₂ , BaTiO ₃ , SrTiO ₃ , (BaSr)TiO ₃ , HfSiO ₂ and ZrSiO ₂ and the like. The metal layer includes gold (Au), silver (Ag), copper (Cu), aluminum (Al), rubidium (Ru), platinum (Pt), iridium (Ir), molybdenum (Mo), palladium (Pd), tungsten ( W) or an alloy thereof.

Hereinafter, the operating principle of the microneedle patch 100 will be described.

As the microneedle patch 100 is attached to the skin of the human body, the microneedle 150 is inserted into the skin of the human body. The microneedle 150 is electrically connected to the electrode part 120 . Specifically, a part of the microneedle 150 is electrically connected to the first electrode part 130 of the electrode part 120 , and another part of the microneedle 150 is electrically connected to the second electrode part 140 . . The electrical signal provided from the power supply unit 160 is the first electrode unit 130 , the microneedle 150 connected to the first electrode unit 130 , the skin internal tissue, and the microneedle 150 connected to the second electrode unit 140 . , and may be transmitted through an electrical path to the second electrode unit 140 . A case in which the electrical signal is transmitted through an electrical path in the opposite direction is also included in the technical spirit of the present invention.

Damaged cells in the skin internal tissues can be healed and restored by these electrical signals. The electrical signal may selectively electrically stimulate the skin internal tissue. In addition, when an active ingredient such as a drug or a cosmetic ingredient is applied to the surface of the microneedle 150, the electric signal enhances the intradermal delivery of the active ingredient and accelerates cell division, thereby effectively promoting skin regeneration treatment. can be done By regeneration through such electrical stimulation, the differentiation of skin cells is accelerated and the regeneration of damaged skin such as wounds, scars, and wrinkles due to aging can be promoted.

Since the microneedle 150 contains biodegradable metal, even if the residue remains in the skin when removed from the skin after the function is finished, the microneedle 150 may be absorbed into the body and disappear. In addition, since the microneedle 150 is naturally decomposed in the body, it is possible to minimize the problem of infection and side effects caused by the residue. Also, when the electrode part 120 includes a biodegradable metal, it may be absorbed into the body and disappear as described above.

3 is a real photograph showing in detail the electrode part 120 and the microneedle 150 of the microneedle patch 100 of FIG. 1 according to an embodiment of the present invention.

Referring to FIG. 3 , the electrode part 120 may include a through hole 180 . The microneedle 150 may be disposed to protrude within the through hole 180 . The first electrode part 130 and the second electrode part 140 are disposed to be spaced apart from each other. In this case, the electrode part 120 and the microneedle 150 may be formed of the same material. The through hole 180 may be formed in the following way. For example, a photoresist pattern (not shown) is formed on the electrode part 120 , and a part of the electrode part 120 is removed by wet etching or dry etching using the photoresist pattern to remove the through hole 180 . ) can be formed. The through hole 180 can accommodate an active ingredient such as a drug or a cosmetic ingredient, and by supplying the active ingredient to the microneedle 150 , the active ingredient can be penetrated into the skin through the microneedle 150 . have.

4 to 6 are schematic views showing the electrode part 120 of the microneedle patch 100 of FIG. 1 according to an embodiment of the present invention.

Referring to FIG. 4 , the electrode part 120a includes a first electrode part 130a and a second electrode part 140a. The first electrode part 130a and the second electrode part 140a may be alternately disposed. The first electrode unit 130a may include a first coalescing unit 132a and a plurality of first extension units 134a differentiated from and extending from the first coalescing unit 132a. The first electrode part 130a may include a first external connection part 136a connected to at least one of the first extension parts 134a. The second electrode unit 140a may include a second coalescing unit 142a and a plurality of second extension units 144a that are differentiated from and extend from the second coalescing unit 142a. The second electrode part 140a may include a second external connection part 146a connected to at least one of the second extension parts 144a. The first extension parts 134a and the second extension parts 144a may be alternately disposed to be spaced apart from each other.

Referring to FIG. 5 , the electrode part 120b includes a first electrode part 130b and a second electrode part 140b. The first electrode part 130b and the second electrode part 140b may be alternately disposed. The first electrode part 130b may extend to be wound inwardly in the first rotational direction. The second electrode part 140b may extend so as to be wound inward in a second rotational direction opposite to the first rotational direction. Also, the second electrode units 140b may be disposed to be spaced apart from each other between the first electrode units 130b. The first electrode part 130b and the second electrode part 140b may extend to be wound in a circular shape, an oval shape, or various curved shapes. The first electrode part 130b may include a first external connection part 136b at one end. The second electrode part 140b may include a second external connection part 146b at one end.

Referring to FIG. 6 , the electrode part 120c includes a first electrode part 130c and a second electrode part 140c. The first electrode part 130c and the second electrode part 140b may be alternately disposed. The first electrode part 130c may extend to be wound inwardly in the first rotational direction. The second electrode unit 140c may extend so as to be wound inward in a second rotational direction opposite to the first rotational direction. Also, the second electrode units 140c may be disposed to be spaced apart from each other between the first electrode units 130c. The first electrode part 130c and the second electrode part 140c may extend in a straight line, for example, to be wound in a triangular shape, a square shape, or various polygonal shapes. The first electrode part 130c may include a first external connection part 136c at one end. The second electrode unit 140c may include a second external connection unit 146c at one end.

As described with reference to FIGS. 4 to 6 , the first electrode part 130 and the second electrode part 140 are alternately arranged in various ways, so that the microneedle 150 can be arranged in a large area, An electric field can be provided uniformly.

Hereinafter, the microneedle 150 will be described in detail.

7 is a perspective view showing the micro-needle 150 of the micro-needle patch 100 of FIG. 1 according to an embodiment of the present invention.

8 to 10 are cross-sectional views illustrating the microneedles 150 of the microneedle patch 100 of FIG. 1 according to an embodiment of the present invention.

11 is a cross-sectional view schematically illustrating a phototherapy by attaching a light patch (L) to the microneedle patch 100 of FIG. 1 according to an embodiment of the present invention.

7 to 11 , the microneedle 150 may include an optical groove portion 152 and a through slot portion 154 . The electrode unit 120 may be formed in a flat plate shape to be attached to the patient's skin (S). More specifically, the electrode part 120 has a thin rectangular shape, and a plurality of microneedles 150 may protrude from one surface of the electrode part 120 . As such, the electrode part 120 and the microneedle 150 may be formed of the same material as an integral body. For example, it may be formed of a metal material suitable for use in the human body as it is harmless to the human body, and for example, at least one or more of titanium, titanium alloy, stainless steel, cobalt-chromium alloy, zinc, zinc alloy, magnesium, and magnesium alloy. can be formed with

The electrode part 120 has a flexible property in the shape of a thin rectangular thin plate, so that it can be naturally deformed and adhered according to the shape and curvature of the skin S of the human body, like a Dynamic Compression Plate (DCP). . In addition, an adhesive sheet is formed on one surface of the electrode part 120 to induce the electrode part 120 to more firmly adhere to the skin S of the human body. For example, the pressure-sensitive adhesive sheet may be formed on the lower surface of the electrode part 120 in contact with the skin S, and is formed on the upper surface of the electrode part 120 to have a larger area than the electrode part 120 to form the electrode part 120 . An extra area other than the covering portion may be attached to the skin (S).

A plurality of microneedles 150 are formed at regular intervals along both sides of the electrode part 120 in the form of a thin plate, and the drug (W) passes through the stratum corneum of the skin (S) directly into the inner tissue of the skin (S). can convey More specifically, the microneedle 150 is formed to become smaller in width from the connecting portion with the electrode 120 toward the tip so that it can easily penetrate the stratum corneum of the skin S, so that the tip is sharp. It may be formed in a shape. As such, the microneedle 150 may be formed in a cone shape, a triangular pyramid shape, or a quadrangular pyramid shape with a pointed tip, and if it is a shape that can penetrate through the stratum corneum of the skin (S), the shape is not particularly limited. can In addition, in the present embodiment, although six microneedles 150 are shown in the form in which six are formed along both sides of the electrode part 120, this is exemplary and not limited thereto.

In addition, when the microneedle 150 penetrates into the skin (S), the drug (W) is coated on the surface of the microneedle 150 so that the drug (W) can also penetrate into the inside of the skin (S). is formed, or a groove (Groove) is formed on one surface of the microneedle 150, and the drug (W) may be filled in the groove. The drug (W) that penetrates into the skin (S) together with the microneedle 150 may be a kind of physiologically active substance (Physiological Active Substance). The physiologically active substance refers to compounds and molecules that are applied to a host, animal, and human to induce a biological response, and for example, a vaccine, an antibody, an antitumor, insulin, a therapeutic substance such as an analgesic and a hair growth agent (Therapeutic). substances) or cosmetic substances such as retinol having anti-aging and whitening effects. In addition, the physiologically active substance may include a non-therapeutic substance such as a lipolysis substance for diet or an anesthetic.

As described above, the drug (W), which is a kind of the physiologically active material, is formed in the form of an electrolyte or non-electrolyte solution or gel, coated on the surface of the microneedle 150, or the groove formed on one surface of the microneedle 150 can be filled in. In the present invention, since the groove can be used as an optical path through which the treatment light passes during phototherapy, which will be described later, it may be preferable that the drug W be formed in the microneedle 150 in the form of filling the groove. In addition, it may be most preferable for the groove to be filled with a transparent drug so that the treatment light can easily pass through the groove.

As such, the groove is an optical groove portion 152 through which the treatment light P can pass. More specifically, as shown in FIGS. 7 to 11 , the optical groove portion 152 is a light source L during phototherapy. ) may be concavely formed along the longitudinal direction of the microneedle 150 so that the treatment light P irradiated from the microneedle 150 can easily penetrate to the inside of the skin S along the microneedle 150 .

At this time, a part of the electrode part 120 and a part of the microneedle 150 so that the treatment light P irradiated from the light source L can easily reach the optical groove part 152 formed in the microneedle 150 . The through slot portion 154 may be formed to pass through the hole in a slot shape and connected to one side of the optical groove portion 152 . Accordingly, the treatment light P irradiated from the light source L passes through the slot-shaped through-slot part 154 formed over the electrode part 120 and the micro-needle 150 connection part and the upper part of the micro-needle 150, Reaching one end of the optical groove portion 152, then, the treatment light (P) passes through the optical groove portion 152 to reach the pointed tip of the microneedle 150, so that it is easy to deep inside the skin (S) can penetrate deeply.

In addition, the optical groove part 152 may be formed in at least one of the plurality of microneedles 150 formed in the electrode part 120 . For example, depending on the amount of drug (W) injected through the microneedle 150 or the required phototherapy area, it may be formed on all of the microneedles 150 or selectively formed on some of the microneedles 150 . At this time, the length of the optical groove 152 may be formed to be the same as the length of the microneedle 150, but depending on the effective penetration depth for each wavelength of the treatment light P, the optical groove portion ( 152) may also be determined.

The optical groove 152 may be formed by cutting the microneedle 150 in the thickness direction by laser processing. However, it is not necessarily limited thereto, and is formed by etching the microneedle 150 in the thickness direction using chemical processing, or cutting the microneedle 150 in the thickness direction using physical machining. may be formed.

As described above, the optical groove portion 152 processed in the form of a groove along the longitudinal direction of the microneedle 150 forms an optical path of the treatment light P irradiated from the light source L, as shown in FIG. 9 . It can serve not only to play a role, but also to accept the drug (W). In addition, when the microneedle 150 is inserted into the skin S, the skin S may penetrate even to the inside of the optical groove 152. In this case, the optical groove 152 is filled with the skin S to provide treatment light. The optical path of (P) cannot be formed. Accordingly, it may be preferable that the width direction length D1 of the optical groove portion 152 is smaller than the depth direction length D2 so that the skin S does not penetrate into the optical groove portion 152 . Therefore, the optical groove 152 is formed deep enough to have a narrow width, so that even if the skin S penetrates into the inside of the optical groove 152, only a portion of the region is filled, so that the treatment light P can pass. It is possible to maintain a light path.

In addition, as shown in FIG. 10 , when the optical groove portion 152 is formed by the laser processing, the metal material that has been melted around the optical groove portion 152 is solidified again by adjusting the laser processing conditions to form the optical groove portion 152 . Protrusions 156 that are formed to protrude on both sides of the can be formed. In this way, by adjusting the processing conditions of the laser processing so that the protrusions 156 are formed on both sides of the optical groove portion 152, the depth direction length D2 compared to the width direction length D1 of the optical groove portion 152 is made deeper. can be formed Accordingly, by guiding the optical groove 152 to be formed deeper while having a narrow width, it is possible to more effectively prevent the skin S from penetrating into the optical groove 152 .

Accordingly, as shown in FIG. 11 , after attaching the microneedle patch 100 to the skin S, a light patch L having a plurality of light sources formed thereon is formed to perform drug treatment and light treatment in parallel. , the treatment light (P) irradiated from the light patch (L) can be guided to penetrate deeply into the interior of the skin (S) along the microneedle (150). For example, although it depends on the wavelength of the treatment light P irradiated from the light patch L, the effective penetration depth in the skin S of general visible light is known to be around 500 μm at most, and a separate optical groove is provided in the microneedle 150. If the 152 is not formed, the treatment light (P) cannot penetrate deeply into the inner side of the skin (S). However, in order to overcome this, as in the present invention, when an optical groove 152 is formed in the microneedle 150 and used as an optical path, the treatment light P is filled inside the optical groove 152 . It is possible to penetrate deep inside the skin (S) through the drug (W).

Therefore, the microneedle patch according to various embodiments of the present invention forms an optical groove 152 in the microneedle 150 and uses it as an optical path, so that the treatment light having a wavelength of visible light or less ( It is possible to extend the penetration depth of the inner skin (S) of P) beyond the depth of the microneedle (150). Therefore, the treatment light (P) is effectively penetrated with the drug (W) into the tissue within the skin (S) can have the effect of maximizing the therapeutic effect of the patient through the interaction between the drug treatment and the light treatment.

12 is a schematic diagram illustrating a simulation device for an operation test of a microneedle patch according to an embodiment of the present invention.

13 is a photograph showing a simulation device for an operation test of a microneedle patch according to an embodiment of the present invention.

12 and 13 , in the simulation device, a membrane was used to simulate the epidermis and keratin of the skin, and collagen was used to simulate the tissue in the skin. The magnesium electrode mimics a microneedle. Active ingredients such as drugs or cosmetic ingredients to be injected were simulated as fluorescent dyes including rhodamine. The magnesium electrode was arranged to penetrate the collagen, and the fluorescent dye was set to flow and penetrate into the collagen.

FIG. 14 shows a result of not applying an electrical signal to the simulating device of the microneedle patch of FIG. 13 according to an embodiment of the present invention.

Referring to FIG. 14, (a) shows the conditions and results of the microneedle patch operation test, and (b) shows a photo showing the degree of penetration of a fluorescent dye (rhodamine) into collagen. In this case, since there is no application of an electrical signal, it can be seen that the fluorescent dye is transmitted only by diffusion due to a difference in concentration.

15 and 16 show a result of applying an electrical signal to the simulating device of the microneedle patch of FIG. 13 according to an embodiment of the present invention.

15 and 16 , DC 1.63V was applied as the electrical signal. 15 (a) shows the conditions and results of the microneedle patch operation test, and FIGS. 15 (b) and 16 show pictures showing the degree of penetration of a fluorescent dye (which is rhodamine) into collagen. . It can be seen that the transmission of the fluorescent dye is greater than when no electrical signal is applied. That is, in this case, since an electric signal is applied, it can be seen that the fluorescent dye is further transmitted by the driving force by the electric field along with diffusion due to the concentration difference.

FIG. 17 is a graph showing the results for the apparatus for simulating the microneedle patch of FIG. 13 according to an embodiment of the present invention.

Referring to FIG. 17 , when an electrical signal was applied to the microneedle patch imitation device compared to the case where the electrical signal was not applied, the area through which the fluorescent dye was transmitted was increased by about 45%. It can be seen that this increase in the transmission area further increases with time.

18 and 19 show the results when triboelectric electricity is applied to the simulating device of the microneedle patch according to an embodiment of the present invention.

18 and 19 , triboelectric electricity was generated at various frequencies. This triboelectricity was controlled to use only the (+) component using a diode. Even when triboelectric electricity was applied, results similar to those in the case where the DC electrical signal of FIGS. 15 to 17 were applied were shown. At 1 Hz, the area through which the fluorescent dye was transmitted was the largest. Therefore, it can be seen that the microneedle patch can use triboelectric power as a power source.

In the conventional case, when trying to deliver a drug or a physiologically active material with a biodegradable metal microneedle, there are the following problems. Drugs coated on the needle or injected along the needle penetrating the stratum corneum and epidermal layer depend purely on diffusion, and a complex instrument is required to increase or precisely control the drug injection rate. Therefore, in order to solve this problem, a means for accelerating or controlling drug injection from the microneedle is required. The microneedle patch according to the technical idea of the present invention can achieve acceleration and control of drug injection using an electric field through electrodeization of the microneedle. Specifically, the microneedle, which is a conductor, consists of two electrodes crossing each other. Accordingly, the ionizable drug molecules coated on the surface of the microneedle or injected along the surface move rapidly by the electric field in the direction of the intersecting near electrode, thereby providing the effect of accelerating drug injection and drug diffusion, and in the electric field itself It can provide a healing effect by A power supply and electrical control device can connect a battery-mounted device to the patch to control drug release and diffusion during attachment, and both direct and alternating current are available. In addition, it is possible to connect and use an electric energy harvesting device such as a triboelectric force harvesting device and a piezoelectric generator that can be operated by human motion. For example, it can be used in the form of activating the function of a patch by generating electricity, although it looks like a makeup operation on the outside by installing it inside a cosmetic puff.

The technical spirit of the present invention described above is not limited to the above-described embodiments and the accompanying drawings, and it is the technical spirit of the present invention that various substitutions, modifications and changes are possible without departing from the technical spirit of the present invention. It will be apparent to those of ordinary skill in the art to which this belongs.

100: micro-needle patch, 110: substrate,
120, 120a, 120b, 120c: electrode part;
130, 130a, 130b, 130c: a first electrode part;
132a: a first coalescing portion, 134a: a first extension portion;
136a, 136b, 136c first external connection;
140, 140a, 140b, 140c: a second electrode part;
142a: second coalescing portion, 144a: second extension portion;
146a, 146b, 146c second external connection;
150: microneedle, 152: optical groove,
154: through slot portion, 156: protrusion;
160: power unit, 170: wiring,
180: through hole

Claims (20)

An electrode unit that provides an electrical signal in contact with the patient's skin and includes a first electrode unit and a second electrode unit spaced apart from the first electrode unit; and
A plurality of microneedles connected to the electrode part, formed at regular intervals along the electrode part, and passing through the stratum corneum of the skin to deliver the active ingredient directly to the tissue inside the skin; including,
microneedle patch. The method of claim 1,
The first electrode part and the second electrode part are alternately arranged with each other,
microneedle patch. The method of claim 1,
The first electrode part includes a first coalescing unit and a plurality of first extension units differentiated from and extending from the first coalescing unit;
The second electrode part includes a second coalescing unit and a plurality of second extension units differentiated from and extending from the second coalescing unit;
The first extension parts and the second extension parts are spaced apart from each other and alternately arranged,
microneedle patch. The method of claim 1,
The first electrode portion extends to be wound inwardly in a first rotational direction,
The second electrode portion extends to be wound inward in a second rotational direction opposite to the first rotational direction and is disposed to be spaced apart between the first electrode portions,
microneedle patch. 5. The method of claim 4,
The first electrode part and the second electrode part each extend in a curved shape,
microneedle patch. 5. The method of claim 4,
The first electrode part and the second electrode part each extend in a straight line,
microneedle patch. The method of claim 1,
The electrode part has a through hole, and the microneedle is disposed to protrude in the through hole,
The through-hole accommodates the active ingredient and supplies the active ingredient to the micro-needle, thereby allowing the active ingredient to penetrate into the skin through the micro-needle,
microneedle patch. The method of claim 1,
The electrode part, the adhesive sheet is formed on one surface so as to be adhered to the skin,
microneedle patch. The method of claim 1,
A power supply unit electrically connected to the electrode unit to provide power; further comprising:
microneedle patch. 10. The method of claim 9,
The power supply unit provides DC power, AC power, RF power, or pulse power to the electrode unit,
microneedle patch. 10. The method of claim 9,
The power unit consists of a galvanic battery or a triboelectric generator,
microneedle patch. 10. The method of claim 9,
The power supply includes a battery consisting of an iron electrode, a hydrogel, and a magnesium electrode,
microneedle patch. The method of claim 1,
The microneedle is formed to have a narrower width from the connecting portion with the electrode to the tip so as to easily pass through the stratum corneum of the skin, so that the tip is formed in a sharp shape,
microneedle patch. The method of claim 1,
The microneedle further includes an optical groove formed concavely along the longitudinal direction of the microneedle so that, during phototherapy, the treatment light irradiated from the light source along the microneedle can easily penetrate to the inside of the skin. doing,
microneedle patch. 15. The method of claim 14,
The microneedle is formed to pass through a part of the patch body and a part of the microneedle in a slot shape so that the treatment light can easily reach the optical groove formed in the microneedle, so that one side of the optical groove and Further comprising; a through slot portion to be connected
microneedle patch. 15. The method of claim 14,
The optical groove portion, the length in the width direction is formed to be smaller than the length in the depth direction so that the tissue of the skin does not block the optical path of the treatment light by filling the optical groove portion,
microneedle patch. 15. The method of claim 14,
The optical groove portion, during the laser processing, the metal material melted around the optical groove portion is solidified to protrude on both sides of the optical groove portion; further comprising a,
microneedle patch. The method of claim 1,
The electrode part includes copper (Cu), aluminum (Al), iron (Fe), magnesium (Mg), titanium (Ti), gold (Au), silver (Ag), rubidium (Ru), platinum (Pt), iridium (Ir), molybdenum (Mo), palladium (Pd), zinc (Zn), silicon (Si), nickel (Ni), tin (Sn), tungsten (W), iron (Fe), calcium (Ca), potassium (K), including sodium (Na), a-IGZO, germanium (Ge) or alloys thereof,
microneedle patch. The method of claim 1,
The microneedle is, magnesium (Mg), iron (Fe), zinc (Zn), molybdenum (Mo), tungsten (W), calcium (Ca), potassium (K), sodium (Na), silicon (Si), a-IGZO, including germanium (Ge) or alloys thereof,
microneedle patch. The method of claim 1,
Further comprising a substrate on which the electrode part is disposed,
The substrate is polyimide, polydimethylsiloxane (PDMS), PMMA, ecoflex, dragon-skin, PVP, PVA, poly(lactic-co-glycolic acid (PLGA), silk fibroin, polycaprolactone (PCL) Containing at least one of, poly glycolic acid (PGA), poly lactic acid (PLA), poly glycerol sebacate (PGS), PBAT, collagen and rice paper, agarose gel, and polyanhydrides,
microneedle patch.

Images